Astera Labs (NASDAQ:ALAB) Stock Price Down 6.9% - Should You Sell?

Key Points

• Astera Labs shares fell 6.9% to about $288.85 in heavy trading, below both the 50-day moving average of $327.83 and the analyst consensus price target of $348.33.
• Analysts maintain a broadly positive outlook, with one Strong Buy, twelve Buy, and eight Hold ratings, producing a consensus “Moderate Buy” rating.
• The company reported strong quarterly results, including $0.80 EPS versus $0.69 expected and 104.5% year-over-year revenue growth, though insiders have sold about $209.7 million of stock over the past 90 days.

Astera Labs, Inc. (NASDAQ:ALAB - Get Free Report)'s share price dropped 6.9% during mid-day trading on Tuesday . The company traded as low as $286.97 and last traded at $288.85. 5,694,255 shares changed hands during trading, an increase of 7% from the average session volume of 5,309,042 shares. The stock had previously closed at $310.40.

Wall Street Analyst Weigh In

A number of research firms have commented on ALAB. Bank of America raised their price target on shares of Astera Labs from $240.00 to $450.00 and gave the stock a "neutral" rating in a report on Tuesday, June 23rd. Morgan Stanley increased their price objective on Astera Labs to $335.00 and gave the stock an "overweight" rating in a research note on Monday, August 3rd. Northland Securities raised shares of Astera Labs from a "market perform" rating to an "outperform" rating and set a $350.00 price target on the stock in a research report on Monday, August 17th. Jefferies Financial Group boosted their price objective on Astera Labs from $270.00 to $450.00 and gave the stock a "buy" rating in a research report on Wednesday, August 5th. Finally, Evercore reissued an "outperform" rating and set a $297.00 target price on shares of Astera Labs in a research report on Tuesday, May 19th. One equities research analyst has rated the stock with a Strong Buy rating, twelve have issued a Buy rating and eight have issued a Hold rating to the company's stock. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus price target of $348.33.

Astera Labs Stock Performance

The stock has a market capitalization of $50.11 billion, a PE ratio of 143.00 and a beta of 3.77. The business's 50-day moving average price is $327.83 and its 200 day moving average price is $256.56.

Astera Labs (NASDAQ:ALAB - Get Free Report) last released its quarterly earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share for the quarter, beating the consensus estimate of $0.69 by $0.11. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%.The firm had revenue of $392.40 million for the quarter, compared to analysts' expectations of $360.85 million. During the same quarter last year, the firm posted $0.44 EPS. The company's revenue was up 104.5% compared to the same quarter last year. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. As a group, equities research analysts predict that Astera Labs, Inc. will post 2.7 earnings per share for the current year.

Insider Buying and Selling at Astera Labs

In other Astera Labs news, CEO Jitendra Mohan sold 90,630 shares of Astera Labs stock in a transaction dated Monday, August 17th. The stock was sold at an average price of $340.35, for a total transaction of $30,845,920.50. Following the completion of the sale, the chief executive officer owned 1,266,665 shares of the company's stock, valued at $431,109,432.75. The trade was a 6.68% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Stefan Dyckerhoff sold 3,505 shares of the business's stock in a transaction that occurred on Wednesday, September 2nd. The stock was sold at an average price of $274.96, for a total value of $963,734.80. Following the completion of the sale, the director owned 50,456 shares of the company's stock, valued at $13,873,381.76. The trade was a 6.50% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders have sold 592,244 shares of company stock valued at $209,729,973. 10.40% of the stock is currently owned by company insiders.

Institutional Trading of Astera Labs

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. California State Teachers Retirement System increased its position in shares of Astera Labs by 49,273.2% in the second quarter. California State Teachers Retirement System now owns 100,158,544 shares of the company's stock valued at $48,378,580,000 after acquiring an additional 99,955,684 shares during the period. BlackRock Inc. bought a new stake in shares of Astera Labs in the second quarter worth about $6,609,581,000. Bank of America Corp DE purchased a new position in Astera Labs during the 2nd quarter valued at about $1,061,791,000. Atreides Management LP increased its holdings in Astera Labs by 108.9% during the 1st quarter. Atreides Management LP now owns 3,365,787 shares of the company's stock valued at $368,890,000 after purchasing an additional 1,754,593 shares during the period. Finally, Amundi raised its position in Astera Labs by 1,298.6% during the 3rd quarter. Amundi now owns 1,421,263 shares of the company's stock valued at $278,283,000 after purchasing an additional 1,319,643 shares during the last quarter. Institutional investors own 60.47% of the company's stock.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company's product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.